Tina Koval
Adult Health · Willoughby, OHNPI 1518495316
Payments from drug & device makers
Across 298 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$585
- Lilly USA, LLC$465
- Phathom Pharmaceuticals, Inc.$234
- Pfizer$210
- Amgen$199
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,882100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 67 | $1,320 |
| Novo Nordisk | 47 | $585 |
| Lilly USA, LLC | 41 | $465 |
| Phathom Pharmaceuticals, Inc. | 2 | $234 |
| Pfizer | 14 | $210 |
| Amgen | 11 | $199 |
| AstraZeneca | 13 | $186 |
| Boehringer Ingelheim | 12 | $177 |
| Merck | 12 | $172 |
| Novartis | 10 | $169 |
| Bayer | 12 | $155 |
| Abbott | 7 | $153 |
| Sanofi-aventis U.S. LLC | 7 | $116 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| GSK | 4 | $69 |
| Jazz Pharmaceuticals Inc. | 3 | $67 |
| E.r. Squibb & Sons, L.L.C. | 4 | $61 |
| Johnson & Johnson | 3 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $40 |
| Biohaven Pharmaceuticals, Inc. | 2 | $36 |
| Astellas Pharma US Inc | 2 | $26 |
| Amarin Pharma, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| Boston Scientific | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| Dynavax Technologies Corporation | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
| Radius Health, Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,882 in reported general payments places this provider in the 90th percentile of 1,184 adult health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 271 | $725 |
| Losartan Potassium | 14 | $221 |
| Levothyroxine Sodium | 15 | $176 |
| Atorvastatin Calcium | 25 | $169 |
| Pantoprazole Sodium | 12 | $143 |
| Omeprazole | 13 | $92 |
| Amlodipine Besylate | 19 | $68 |
| Lisinopril | 18 | $57 |
| Hydrochlorothiazide | 14 | $50 |
Paid to pharmacies, not to this prescriber.
Other adult health in Willoughby
- Laura FrycklundWilloughby$12K
- Bonnie MohlerCanton$338K
- Andrew GuinigundoCincinnati$215K
- Gabriella McCartyWestlake$177K
- Karen SteffeyLyndhurst$145K
- Marie ChambersCenterville$134K
- Susan FlickCleveland$131K
- Margaret TiktinCleveland$105K
- Teresa ShafferBoardman$102K
- Jesse McClainYoungstown$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.